473 related articles for article (PubMed ID: 10627532)
21. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
[TBL] [Abstract][Full Text] [Related]
22. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
[TBL] [Abstract][Full Text] [Related]
23. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
[TBL] [Abstract][Full Text] [Related]
24. Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.
Dickerson SJ; Xing Y; Robinson AR; Seaman WT; Gruffat H; Kenney SC
PLoS Pathog; 2009 Mar; 5(3):e1000356. PubMed ID: 19325883
[TBL] [Abstract][Full Text] [Related]
25. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
26. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.
Liu P; Liu S; Speck SH
J Virol; 1998 Oct; 72(10):8230-9. PubMed ID: 9733866
[TBL] [Abstract][Full Text] [Related]
27. Retinoblastoma protein interacts with ATF2 and JNK/p38 in stimulating the transforming growth factor-beta2 promoter.
Li H; Wicks WD
Arch Biochem Biophys; 2001 Oct; 394(1):1-12. PubMed ID: 11566021
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.
Ruf IK; Rawlins DR
J Virol; 1995 Dec; 69(12):7648-57. PubMed ID: 7494273
[TBL] [Abstract][Full Text] [Related]
30. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
Robinson AR; Kwek SS; Kenney SC
PLoS Pathog; 2012 Feb; 8(2):e1002516. PubMed ID: 22346751
[TBL] [Abstract][Full Text] [Related]
31. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
[TBL] [Abstract][Full Text] [Related]
32. The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication.
Chatila T; Ho N; Liu P; Liu S; Mosialos G; Kieff E; Speck SH
J Virol; 1997 Sep; 71(9):6560-7. PubMed ID: 9261377
[TBL] [Abstract][Full Text] [Related]
33. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.
Zalani S; Holley-Guthrie EA; Gutsch DE; Kenney SC
J Virol; 1992 Dec; 66(12):7282-92. PubMed ID: 1331521
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.
Zalani S; Holley-Guthrie E; Kenney S
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9194-9. PubMed ID: 8799177
[TBL] [Abstract][Full Text] [Related]
35. Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.
Wu H; Li T; Zeng M; Peng T
Cell Microbiol; 2012 Apr; 14(4):546-59. PubMed ID: 22188237
[TBL] [Abstract][Full Text] [Related]
36. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
[TBL] [Abstract][Full Text] [Related]
37. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6.
Flamand L; Menezes J
J Virol; 1996 Mar; 70(3):1784-91. PubMed ID: 8627701
[TBL] [Abstract][Full Text] [Related]
38. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.
Bhende PM; Dickerson SJ; Sun X; Feng WH; Kenney SC
J Virol; 2007 Jul; 81(14):7363-70. PubMed ID: 17494074
[TBL] [Abstract][Full Text] [Related]
39. Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.
Liu C; Sista ND; Pagano JS
J Virol; 1996 Apr; 70(4):2545-55. PubMed ID: 8642684
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
